Edition:
United Kingdom

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

5.51USD
15 Jan 2019
Change (% chg)

-- (--)
Prev Close
$5.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,923
52-wk High
$38.68
52-wk Low
$3.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.559
Jun '18 10.14 -0.365
Mar '18 0.50 -0.720
FY 2017 Dec '17 2.78 -0.087
Sep '17 0.91 -0.373
Jun '17
Mar '17 0.45 -1.079
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.28 0.30 0.25 --
Quarter Ending Jun-19 2 0.28 0.30 0.25 --
Year Ending Dec-19 5 0.40 1.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 2 -0.74 -0.63 -0.84 --
Quarter Ending Jun-19 2 -0.77 -0.69 -0.85 --
Year Ending Dec-19 5 -3.22 -2.70 -4.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.38
P/E High - Last 5 Yrs. -- 148.01 46.19
P/E Low - Last 5 Yrs. -- 47.79 24.58
Beta -- 1.08 0.91
Price to Sales (TTM) -- 49.51 6.26
Price to Book (MRQ) -- 10.16 5.20
Price to Tangible Book (MRQ) -- 13.82 6.73
Price to Cash Flow (TTM) -- 52.80 24.17
% Owned Institutions -- 3.75 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.93
Payout Ratio(TTM) -- 7.04 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.04 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 6.48
Sales - 5 Yr. Growth Rate -- 22.76 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.87 23.23
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.30
Current Ratio (MRQ) -- 3.43 3.12
LT Debt to Equity (MRQ) -- 18.73 11.47
Total Debt to Equity (MRQ) -- 31.43 16.03
Interest Coverage (TTM) -- -43.27 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 54.45
Gross Margin - 5 Yr. Avg. -- 60.55 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.00 13.10
Operating Margin (TTM) -- -184.40 6.05
Operating Margin - 5 Yr. Avg. -- -126.43 8.39
Pre-Tax Margin (TTM) -- -175.18 7.01
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.67
Net Profit Margin (TTM) -- -181.91 3.11
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.86
Effective Tax Rate (TTM) -- 21.48 23.27
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,971 873,304,610
Net Income/Employee (TTM) -- 652,631 103,509,255
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.57
Asset Turnover (TTM) -- 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.45 11.45
Return on Assets - 5 Yr. Avg. -- 5.52 12.50
Return on Investment (TTM) -- 8.99 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -- 10.13 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.36

Performance for Menlo Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 98
13 Week -- -- -- 94
26 Week -- -- -- 98
52 Week -- -- -- 68
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 71.67%
# of Holders: 80
Total Shares Held: 16,651,151
3 Mo. Net Change: -1,417,919
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 4
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.